Monson Solar is Nexamp’s Latest Community Solar Project in Massachusetts
Oct 20, 2017 12:00 pm UTC| Business
MONSON, Mass., Oct. 20, 2017 -- Nexamp, Inc., a leading provider of solar energy solutions, today announced the completion of its latest community shared solar array, a 2.6 megawatt (MW) project in Monson,...
MotivAction achieves veteran-owned business certification
Oct 20, 2017 12:00 pm UTC| Business
MINNEAPOLIS, Oct. 20, 2017 -- MotivAction, a global performance improvement company and leader in employee engagement and recognition, sales and channel incentives is proud to announce that it has been certified as a...
Oct 20, 2017 12:00 pm UTC| Business
AMES, Iowa, Oct. 20, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its third quarter 2017 financial results on Thursday, November 2, 2017. The company has scheduled a conference...
American Health Council Recognizes Glenn Taylor, MD, FAAOS as “America’s Best Doctor”
Oct 20, 2017 12:00 pm UTC| Business
NEW YORK, Oct. 20, 2017 -- Dr. Glenn G. Taylor of NOSS – Neurosurgery, Orthopedics Spine Specialists, PC, Waterbury, Connecticut, has been recognized as “America’s Best Doctor” by the American Health Council. He will...
Twin Disc, Inc. Announces Fiscal 2018 First-Quarter Earnings Conference Call and Press Release
Oct 20, 2017 12:00 pm UTC| Business
RACINE, Wis., Oct. 20, 2017 -- Twin Disc, Inc. (NASDAQ:TWIN), today announced that it will release its fiscal 2018 first-quarter financial results before the market opens on Friday, October 27, 2017. In conjunction...
Sotheby’s Third Quarter 2017 Earnings Conference Call Invitation
Oct 20, 2017 12:00 pm UTC| Business
NEW YORK, Oct. 20, 2017 -- Sotheby’s (NYSE:BID) will be holding its third quarter and nine months ended September 30, 2017 earnings conference call on Friday, November 3, 2017 at 9:00 AM EDT. The call will be hosted by...
Spero Therapeutics Initiates Clinical Program for Oral Carbapenem SPR994
Oct 20, 2017 12:00 pm UTC| Business
Clinical study to evaluate potential first ever orally administered carbapenem being developed for multi-drug resistant (MDR) Gram-negative infectionsInitiation of pivotal Phase 3 clinical trial in patients with...